Ryszard Modzelewski

Title: Ryszard Modzelewski: Innovator in Pharmaceutical Chemistry

Introduction

Ryszard Modzelewski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

Latest Patents

Ryszard Modzelewski holds 1 patent related to his research. His patent, titled "Crystalline polymorphs of methanesulfonic acid addition salts of Imatinib," focuses on the methanesulfonic acid addition salts of Imatinib and their synthesis. This invention specifically addresses the synthesis of the crystalline α-form of Imatinib methanesulfonate. Additionally, it introduces a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid, along with its polymorphic forms and pharmaceutical compositions.

Career Highlights

Ryszard Modzelewski is affiliated with the Instytut Farmaceutyczny, where he has been instrumental in advancing pharmaceutical research. His expertise in the synthesis of complex compounds has positioned him as a key figure in his field. His innovative approach to drug formulation has the potential to enhance therapeutic efficacy and patient outcomes.

Collaborations

Ryszard has collaborated with several talented individuals in his field, including Wioleta Maruszak and Urszula Fraczek. These collaborations have fostered a productive research environment, leading to advancements in pharmaceutical sciences.

Conclusion

Ryszard Modzelewski's contributions to pharmaceutical chemistry exemplify the critical role of inventors in advancing medical science. His innovative work on Imatinib derivatives highlights the importance of research and development in creating effective treatments.